Medical school / MD + DO
Good GPA for Medical School
Updated 15 May 2026
The AAMC matriculant median for allopathic (MD) programmes is 3.77 cumulative and 3.71 science. The osteopathic (DO) matriculant median is approximately 3.60. A competitive MD application typically presents 3.5+ with a 510+ MCAT; competitive DO typically presents 3.4+ with a 504+ MCAT. AAMC Table A-23 shows the explicit GPA-MCAT interaction effect; this page reproduces the matrix and explains the strategic implications.
MD vs DO at a glance
Both MD and DO are fully licensed physicians in the United States with the same scope of practice and prescribing authority. The training paths are similar with one structural difference: DO programmes include osteopathic manipulative medicine (OMM) training. Residency match has been unified across MD and DO since 2020 under the single ACGME accreditation system, so DO graduates compete for the same residencies as MD graduates.
The admissions standards differ. AAMC publishes detailed matriculant data for MD programmes in its Facts (Applicants and Matriculants) tables, including Table A-16 (GPA and MCAT for applicants and matriculants) and Table A-23 (acceptance rates by GPA and MCAT). AACOMAS publishes parallel data for DO programmes in its annual Applicant Pool Profile. The summary:
| Programme type | Matriculant median GPA |
|---|---|
| Allopathic (MD) | 3.77 / 3.71 sci |
| Osteopathic (DO) | ~3.60 / 3.50 sci |
| Caribbean MD (Big Four) | ~3.3+ admit |
| Post-bac (Career changer) | Varies |
| Special Master's Programme (SMP) | Varies |
The GPA-MCAT acceptance matrix
The AAMC publishes acceptance rates to MD programmes cross-tabulated by GPA band and MCAT band. The matrix is the single most useful tool for assessing competitiveness because it shows the explicit interaction effect: a high MCAT compensates substantially for a lower GPA. The table below reproduces approximate acceptance rates for the most recent published cycle:
| GPA range | MCAT 528 | MCAT 522 | MCAT 518 | MCAT 514 | MCAT 510 |
|---|---|---|---|---|---|
| 3.80+ | 92% | 85% | 73% | 56% | 36% |
| 3.60-3.79 | 85% | 73% | 60% | 41% | 23% |
| 3.40-3.59 | 73% | 57% | 43% | 27% | 14% |
| 3.20-3.39 | 60% | 42% | 29% | 17% | 8% |
| 3.00-3.19 | 44% | 29% | 19% | 10% | 5% |
| 2.80-2.99 | 31% | 20% | 12% | 6% | 3% |
Acceptance rate to any US MD programme. Source: AAMC Table A-23, most recent published cycle. Verify the current year's table directly at the AAMC Facts page linked above.
The matrix shows several useful patterns. First, MCAT can compensate for GPA: a 3.40-3.59 GPA with a 528 MCAT has a 73% acceptance rate, which is higher than a 3.80+ GPA with a 510 MCAT (36%). Second, the interaction is multiplicative rather than additive: applicants in the bottom-left corner (low GPA, low MCAT) have very low acceptance rates that no single-factor compensation can rescue. Third, the matrix is acceptance rate to any MD programme, not to a specific tier; competitive top-25 MD programmes have stricter effective standards than the matrix suggests.
Science GPA weighs more than cumulative
AAMC reports both cumulative undergraduate GPA and science GPA (BCPM: Biology, Chemistry, Physics, Mathematics). The two values are reported separately on the application and admissions committees weight science GPA heavily because it is the closest available proxy for capability in medical-school coursework.
A student with a 3.8 cumulative and a 3.4 science GPA reads less favourably than a student with a 3.6 cumulative and a 3.7 science GPA at most MD programmes. The gap between cumulative and science is the most common reason for an apparently strong cumulative GPA to underperform in acceptance outcomes. Conversely, a student with a stronger science GPA than cumulative GPA benefits because the science number is the more-weighted signal.
Practical strategy: for pre-med students with weaker grades in non-science courses (often freshman general-education electives), the cumulative-vs-science gap can be acceptable as long as the science GPA stays strong. For pre-med students with the opposite pattern (strong cumulative, weaker science), the science gap is the higher-priority recovery target. Post-bac science coursework specifically addresses this asymmetry.
Post-bac and SMP paths
Two structured recovery paths exist for applicants whose undergraduate GPA is below the matriculant median. Both are well documented and have predictable success rates.
Post-baccalaureate programmes: structured post-undergraduate coursework designed either for career changers (non-science majors completing pre-med prerequisites) or for academic record enhancement (raising the science GPA). The AAMC post-bac directory lists structured programmes at universities across the country. Typical duration is 1-2 years. Successful completion with a 3.7+ post-bac GPA materially improves the application.
Special Master's Programmes (SMPs): graduate-level coursework that mirrors the first year of medical school, designed to demonstrate the applicant's capability to handle medical-school rigour. Many SMPs have linkage agreements with specific MD programmes that guarantee interview consideration for high-performing SMP students. Typical duration is one year. Cost can be substantial (often $50,000-$70,000 for the year), and the strategic case is strongest for applicants whose post-bac alone would not address the academic record question.
DO as a strategic path
For applicants whose GPA is below the MD matriculant median but above the DO matriculant median, DO is a viable strategic path. DO graduates are fully licensed physicians, compete for the same residencies as MD graduates under the unified match, and have the same scope of practice. The OMM training is additional rather than substitutive; many DO graduates use it in primary care, others do not use it at all in subspecialty practice.
The strategic question for a 3.4-3.6 GPA applicant is whether to apply MD-only (with a hard match-or-reapply outcome), DO-only (with higher per-application acceptance probability), or both. The most common recommendation is to apply broadly to both unless there is a strong personal preference for one over the other. The application costs are additive but moderate; the diversification reduces single-cycle reapply risk.
Educational reference. Not admissions advice. Verify current AAMC and AACOMAS data and consult a pre-med advisor for strategy.